Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Cardiol ; 104(5): 732-4, 2009 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-19699353

RESUMEN

Renal artery stenosis is a common cause of secondary hypertension and ischemic nephropathy. Percutaneous angioplasty and stent placement has allowed select patients with renal artery stenosis to use fewer antihypertensive agents and improve or stabilize renal function. The associations of baseline systolic, diastolic, and pulse pressures (PPs) with outcomes of blood pressure (BP) and renal function were examined in 243 patients who underwent renal angioplasty and stent placement. The average PP before the procedure in patients with improvements or stabilizations in renal function was 53 +/- 20 mm Hg, compared to 107 +/- 18 mm Hg (p <0.05) in those with poorer outcomes. The average PPs before procedure were 47 +/- 15 mm Hg in those with improvements in BP, 82 +/- 10 mm Hg in those with stabilizations of BP, and 111 +/- 14 mm Hg in those with worsening BP. All findings were statistically significant (p <0.05). In conclusion, wide PP may reflect more advanced vascular stiffness and renal disease distinguishing patients less likely to benefit from revascularization.


Asunto(s)
Angioplastia de Balón , Presión Sanguínea , Obstrucción de la Arteria Renal/terapia , Anciano , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Sensibilidad y Especificidad , Stents
2.
J Stroke Cerebrovasc Dis ; 17(5): 320-4, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18755413

RESUMEN

Ischemic stroke during sexual intercourse is an unusual occurrence. We report the evaluation and treatment of a young woman on oral contraceptives, with a complex atrial septal abnormality and right lower extremity deep vein thrombus, who had an ischemic stroke during sexual intercourse. Successful treatment was accomplished with administration of intra-arterial tissue plasminogen activator and subsequent transvascular occlusion of the atrial septal abnormality.


Asunto(s)
Foramen Oval Permeable/complicaciones , Aneurisma Cardíaco/complicaciones , Defectos del Tabique Interatrial/complicaciones , Infarto de la Arteria Cerebral Media/patología , Conducta Sexual/fisiología , Trombosis de la Vena/complicaciones , Adulto , Anticoagulantes/uso terapéutico , Angiografía Cerebral , Ecocardiografía , Femenino , Fibrinolíticos/uso terapéutico , Heparina/uso terapéutico , Humanos , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Pierna/irrigación sanguínea , Esfuerzo Físico , Terapia Trombolítica/métodos , Activador de Tejido Plasminógeno/uso terapéutico , Resultado del Tratamiento
3.
J Invasive Cardiol ; 19(7): 291-4, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17620672

RESUMEN

BACKGROUND: Conflicting opinion exists regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). We sought to evaluate the influence of ASA dose on the incidence of unexplained subacute and late stent thrombosis in the era of DES. METHODS: We performed a retrospective analysis of the incidence of subacute and late stent thrombosis in our patient population over a 2-year period. The analysis was limited to patients being discharged and maintained on a daily ASA dose of either 81 mg or 325 mg and having received at least 1 sirolimus-eluting stent. RESULTS: During the study period, 1,093 patients (1,807 separate PCI procedures) met the inclusion criteria. The incidence of unexplained subacute and late stent thrombosis was 1.1% in the study population (12 out of 1,093 patients). When considering the total number of individual procedures performed on the study population during the study period (1,807 procedures), the incidence of unexplained subacute or late stent thrombosis was 0.7%. Six were subacute and 6 were late thrombosis. No significant difference was observed in the incidence of stent thrombosis between the 2 ASA dose groups. Seven patients had stent thrombosis in the 81 mg group (1.2% of 583 patients), while 5 had thrombosis in the 325 mg group (1% of 510 patients); p = 0.727. CONCLUSION: In conclusion, we found no significant difference in the incidence of unexplained subacute or late stent thrombosis with the use of an 81 mg versus 325 mg dose of aspirin post-PCI with sirolimus-eluting stents.


Asunto(s)
Angioplastia Coronaria con Balón/instrumentación , Aspirina/administración & dosificación , Materiales Biocompatibles Revestidos , Trombosis Coronaria , Inhibidores de Agregación Plaquetaria/administración & dosificación , Sirolimus/farmacología , Stents , Administración Oral , Anciano , Angiografía Coronaria , Estenosis Coronaria/diagnóstico por imagen , Estenosis Coronaria/terapia , Trombosis Coronaria/diagnóstico por imagen , Trombosis Coronaria/epidemiología , Trombosis Coronaria/prevención & control , Relación Dosis-Respuesta a Droga , Estudios de Seguimiento , Humanos , Inmunosupresores/farmacología , Incidencia , Masculino , Persona de Mediana Edad , Cuidados Posoperatorios/métodos , Estudios Retrospectivos , Resultado del Tratamiento
4.
Catheter Cardiovasc Interv ; 69(2): 303-12, 2007 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-17187434

RESUMEN

OBJECTIVES: We sought to analyze several new hemodynamic characteristics which address the interplay of left atrial (LA) and left ventricular (LV) pressures, as well as to re-analyze several other V wave characteristics employed in the determination of mitral regurgitation (MR) severity in order to determine which, if any, had adequate correlation with grade of MR for clinical utility. BACKGROUND: Invasive assessment of mitral regurgitation includes analysis of intracardiac pressures and LV angiography. The V wave, when obtained from the pulmonary capillary wedge position (PCWP), and its various characteristics are believed to be of limited value for prediction of MR severity. METHOD: We analyzed the transeptal pressure tracings of patients with various degrees of MR. Several relationships from the simultaneous pressure-time curves of the LA and LV were defined. Biplane left ventricular angiography was used to grade MR. Correlation between each parameter and MR grade was determined by calculating a Pearson correlation coefficient. RESULTS: The ratio of the area under the V wave to the LV systolic area (V(a)/LV(a)) best correlates with the degree of MR with a Pearson correlation coefficient of 0.60. The V(a)/LV(a) was significantly lower in patients with 0-1+ MR compared to > or =2+ MR (0.14 vs. 0.23 p = 0.002). CONCLUSIONS: Invasive hemodynamic assessment of MR severity could be enhanced by calculating our new ratio, V(a)/LV(a), due to its ability to account for LV work that is lost to the LA with a proportional decrease in forward or useful LV work with progressively increasing severity of MR.


Asunto(s)
Insuficiencia de la Válvula Mitral/fisiopatología , Adulto , Anciano , Anciano de 80 o más Años , Cateterismo Cardíaco , Angiografía Coronaria , Femenino , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia de la Válvula Mitral/diagnóstico por imagen , Presión Esfenoidal Pulmonar , Índice de Severidad de la Enfermedad
5.
J Heart Lung Transplant ; 23(2): 252-5, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-14761774

RESUMEN

We present the first report of a patient who underwent heart transplantation (HT) after endomyocardial biopsy (EMB) and revealed chloroquine-induced cardiomyopathy (CIC). This patient, who was treated with chloroquine for 6 years, developed a restrictive cardiomyopathy that progressed to congestive heart failure (CHF) resistant to medical management.


Asunto(s)
Antirreumáticos/efectos adversos , Artritis Reumatoide/tratamiento farmacológico , Cardiomiopatía Restrictiva/inducido químicamente , Cardiomiopatía Restrictiva/cirugía , Cloroquina/efectos adversos , Trasplante de Corazón , Antirreumáticos/uso terapéutico , Cloroquina/uso terapéutico , Femenino , Insuficiencia Cardíaca/inducido químicamente , Insuficiencia Cardíaca/cirugía , Humanos , Persona de Mediana Edad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA